Skip to content

RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)

RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05963464
Acronym
RADIOSO
Enrollment
300
Registered
2023-07-27
Start date
2023-02-01
Completion date
2024-12-31
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Occult Breast Carcinoma

Brief summary

This is a monocentric prospective observational study for patients with clinical undetectable breast lesions and indications to breast conserving surgery for histological characterization. The SCOUT® Radar occult breast lesion Localization (SRL) consists of an implantable reflector, a detector handpiece and a console and it uses non-radioactive micro-impulses to guide surgical excision in real time. The study describes the experience with 300 patients at the European Institute of Oncology. The primary endpoints of the study are the rates of successful positioning, localization and recovery of the reflector SRL.

Detailed description

It has been estimated that 31,8% of breast cancer patients undergo pre-operational lesion localization. Of them, 19% have been previously administered neoadjuvant chemotherapy (NACT). Based on retrospective data, NACT administration is believed to steadily increase by 1,3%, each year. The IEO Breast Division Program aims at improving the treatment and planning options available to patients referred for radio guided breast surgery. At IEO, ROLL remains the standard of care. From its inception 25 year ago to the present day,the investigators have gained significant expertise and now perform more than 1000 procedures per year. The investigators believe that SRL (SCOUT® Radar occult breast lesion Localization) could be added to the procedure of reference in the following cases, still under investigation, where it seems to present some advantages when compared to ROLL: 1. Long-term positioning of the reflector, as in the case of patients undergoing neoadjuvant treatment 2. Reflector placement in malignant lymphadenopathy prior to neoadjuvant chemotherapy 3. Placement of multiple reflectors, or use of both SRL and ROLL in patients with multifocal or multicentric neoplasia referred for conservative surgery 4. BI-RADS 5 patients suspected for ductal carcinoma in situ (DCIS) and eligible for conservative surgery, could undergo reflector placement after vacuum-assisted breast biopsy (VABB) and also be scheduled for Monday morning surgery 5. Placement of the reflector using MR-compatible introducer needles

Interventions

DEVICESCOUT® Radar occult breast lesion Localization

The SCOUT® Radar occult breast lesion Localization (SRL) uses non-radioactive micro-impulses to guide surgical excision in real time.

Sponsors

European Institute of Oncology
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of nonpalpable breast or lymph nodes * Patients referred to IEO for breast surgery * Patients between 18 and 90 years old * Female patients * Conservative surgery * Patients willing and able to follow the study procedures and available for follow-up over the entire duration of the study

Exclusion criteria

* Patients known or suspected to be allergic to materials similar to those in the SAVI SCOUT components (nickel) * Any condition that may expose the individual to a higher risk or preclude the study from achieving full compliance or completion.

Design outcomes

Primary

MeasureTime frameDescription
Rate of successful positioning of the reflector1 weekPercentage of reflectors successfull positioned
Rate of successful localization of the reflector6 monthsPercentage of reflectors successfull localized
Rate of successful recovery of the reflector6 monthsPercentage of reflectors successfull recovered

Secondary

MeasureTime frameDescription
Rate of cases with negative margins6 monthspercentage of cases with negative margins
Rate of cases that have required a second excision6 monthsPercentage of cases that have required a second excision

Countries

Italy

Contacts

Primary ContactGianmatteo Pagani, MD
gianmatteo.pagani@ieo.it+390257489
Backup ContactClaudia Sangalli, MSc
claudia.sangalli@ieo.it+390257489

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026